Lv3
250 积分 2026-02-07 加入
Mo1350: COMPARATIVE EFFECTIVENESS OF FEXUPRAZAN AND ESOMEPRAZOLE IN THE MANAGEMENT OF NOCTURNAL ACID BREAKTHROUGH
17天前
已关闭
Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trial
22天前
已完结
High-dose intravenous vitamin C reduce C-reactive protein levels, fluid retention, and APACHE II scores in patients with moderately severe acute pancreatitis: a prospective, randomized, double-blinded, placebo-controlled study
22天前
已完结
Gemcitabine, carboplatin, and Epstein–Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial
1个月前
已完结
Tabelecleucel: First Approval
1个月前
已完结
EBV Reactivation and Lymphomagenesis: More Questions than Answers
2个月前
已完结
Epstein-Barr virus colitis on a background of Crohn’s disease
2个月前
已完结
Emerging drugs for Epstein-Barr virus associated-diseases
2个月前
已完结
Treatment of Epstein-Barr Virus infection in immunocompromised patients
2个月前
已完结
皖公网安备34019202002308
